Abstract:Objective:To evaluate the pathological features of bilateral retinoblastoma (RB) and the relationship between different treatments and high-risk histopathologic features (HHF).Methods:Retrospective series of case studies. From 1999 to 2018, 73 patients with binocular RB diagnosed by pathological examination in Department of Ophthalmology, Peking University People's Hospital were included in the study. Among them, 50 patients were male (68.5%, 50/73), 23 patients were females (31.5%, 23/73); 11 patitents had a family history of RB. The mean age at the first diagnosis was 14.8±15.6 months. The average time between first diagnosis and first intervention was 3.97±4.74 months. According to the international classification standard of intraocular RB staging, among the 73 eyes, C, D and E stages were 2 (2.7%, 2/73), 15 (20.5%, 15/73), and 56 (76.7%, 56/73) eyes, respectively. Ocular images for each patient were obtained using a wide-angle contact fundus camera during examination under general anaesthesia. The treatment protocol (globe salvaging or enucleation) depended on the result of several clinical features. Globe salvaging treatment included chemotherapy combined with local therapy such as intra-arterial chemotherapy (IAC), intravitreal chemotherapeutics injection, cryotherapy, laser, transpupillary thermotherapy and radiotherapy. If globe salvaging failed, enucleation was offered and histopathologic analysis was conducted of the enucleated eye, the ophthalmic pathologist read and evaluated the presence of HHF. Independent samples t-test was performed to compare the continuous variables. The pathological features and the relationship between different treatments and HHF were analyzed. Group difference was calculated with chi-square. Results:Among the 73 eyes, the first treatment was enucleation in 21 eyes (28.8%, 21/73); 52 eyes (71.2%, 52/73) were treated with eye protection. After enucleation, 9 cases (12.3%, 9/73) had recurrence and metastasis, and 7 cases (9.6%, 7/73) died. The intervention time of patients with recurrence and metastasis and those without recurrence and metastasis were 7.4±7.3 and 3.5±4.1 months respectively; the first intervention time of patients with recurrence and metastasis was significantly later than that of patients without recurrence and metastasis, but the difference was not statistically significant ( t=-1.561, P=0.154). The pathological examination results showed that there were 26 eyes (35.6%, 26/73) with HHF, 4 (26.7%, 15/26) and 22 (39.3%, 22/56) eyes were in stage D and E, respectively. Those who received other treatments before enucleation had lower HHF percentages after enucleation than those who did not receive corresponding treatments, but the difference was not statistically significant ( χ2=1.852, 0.074, 0.000, 1.007, 0.007, 2.729; P>0.05). Among the 26 eyes, 5 (83.3%, 5/6) and 21 (31.3%, 21/67) eyes were treated with systemic chemotherapy combined with and without IAC, respectively, and there was a significant difference in the percentage of HHF ( χ2=4.422, P=0.035). Conclusions:IAC eye-preserving therapy before enucleation has a significant effect on HHF.

Histopathologic Risk Factors for Prognosis in Patients with Retinoblastoma

Clinical treatment and prognostic observation for different pathological infiltrations in 537 patients with unilateral retinoblastoma.

Histopathologic Risk Factors of Retinoblastoma: A Retrospective Study of 104 Enucleated Eyes

Evaluation on the Influence of the Histopathological Invasion for the Prognosis of Patients with Retinoblastoma

Relationship between clinical characteristics and prognosis of retinoblastoma

Prognosis of Postenucleation Adjuvant Therapy in Retinoblastoma

Establishment Of The Relationship Between Tumor Size And Range Of Histological Involvement To Evaluate The Rationality Of Current Retinoblastoma Management

Associations among socioeconomic factors, lag time, and high-risk histopathologic features in eyes primarily enucleated for retinoblastoma.

Clinical Prognostic Factors for Central Neurocytoma and Subgroup Analysis of Different Treatment Measures: A SEER Database-Based Retrospective Analysis from 2003 to 2019

Eye-Preserving Therapies for Advanced Retinoblastoma

Retrospective clinical study on the comprehensive treatment of retinoblastoma

Clinicopathologic Features And Prognostic Factors Of Malignant Eyelid Tumors

Long-term surgical outcomes and prognostic factors for advanced-stage retinopathy of prematurity after vitrectomy

The cinical analysis of 317 cases of retinoblastoma

Analysis of the association between different treatments and high-risk histopathologic features of bilateral retinoblastomas

Risk factors for cataract in retinoblastoma management

Does Vitreous Haemorrhage and Calcification Lead to Increased Risk of Enucleation in Advanced Retinoblastoma?

Clinical Characteristics and Prognosis of Patients with Retinoblastoma: 8-Year Follow-Up.

Contemporary Update of Retinoblastoma in China: Three-Decade Changes in Epidemiology, Clinical Features, Treatments, and Outcomes

Association of choroidal invasion with retinoblastoma survival rates

Analysis on Therapeutic Outcomes and Prognostic Factors of Intracranial Ependymoma: A Report of 49 Clinical Cases in A Single Center